QQQ   415.52 (+0.21%)
AAPL   165.61 (+0.37%)
MSFT   398.78 (-0.09%)
META   479.68 (-0.29%)
GOOGL   155.21 (+0.73%)
AMZN   175.49 (+0.49%)
TSLA   140.78 (-4.26%)
NVDA   779.59 (+2.31%)
AMD   147.61 (+0.66%)
NIO   3.87 (+1.84%)
BABA   70.14 (+1.55%)
T   16.29 (-1.33%)
F   12.62 (+3.95%)
MU   107.82 (+0.98%)
GE   149.74 (+1.13%)
CGC   7.72 (-2.65%)
DIS   112.08 (-0.47%)
AMC   3.39 (+7.28%)
PFE   26.37 (+1.42%)
PYPL   62.73 (+0.67%)
XOM   120.59 (+0.59%)
QQQ   415.52 (+0.21%)
AAPL   165.61 (+0.37%)
MSFT   398.78 (-0.09%)
META   479.68 (-0.29%)
GOOGL   155.21 (+0.73%)
AMZN   175.49 (+0.49%)
TSLA   140.78 (-4.26%)
NVDA   779.59 (+2.31%)
AMD   147.61 (+0.66%)
NIO   3.87 (+1.84%)
BABA   70.14 (+1.55%)
T   16.29 (-1.33%)
F   12.62 (+3.95%)
MU   107.82 (+0.98%)
GE   149.74 (+1.13%)
CGC   7.72 (-2.65%)
DIS   112.08 (-0.47%)
AMC   3.39 (+7.28%)
PFE   26.37 (+1.42%)
PYPL   62.73 (+0.67%)
XOM   120.59 (+0.59%)
QQQ   415.52 (+0.21%)
AAPL   165.61 (+0.37%)
MSFT   398.78 (-0.09%)
META   479.68 (-0.29%)
GOOGL   155.21 (+0.73%)
AMZN   175.49 (+0.49%)
TSLA   140.78 (-4.26%)
NVDA   779.59 (+2.31%)
AMD   147.61 (+0.66%)
NIO   3.87 (+1.84%)
BABA   70.14 (+1.55%)
T   16.29 (-1.33%)
F   12.62 (+3.95%)
MU   107.82 (+0.98%)
GE   149.74 (+1.13%)
CGC   7.72 (-2.65%)
DIS   112.08 (-0.47%)
AMC   3.39 (+7.28%)
PFE   26.37 (+1.42%)
PYPL   62.73 (+0.67%)
XOM   120.59 (+0.59%)
QQQ   415.52 (+0.21%)
AAPL   165.61 (+0.37%)
MSFT   398.78 (-0.09%)
META   479.68 (-0.29%)
GOOGL   155.21 (+0.73%)
AMZN   175.49 (+0.49%)
TSLA   140.78 (-4.26%)
NVDA   779.59 (+2.31%)
AMD   147.61 (+0.66%)
NIO   3.87 (+1.84%)
BABA   70.14 (+1.55%)
T   16.29 (-1.33%)
F   12.62 (+3.95%)
MU   107.82 (+0.98%)
GE   149.74 (+1.13%)
CGC   7.72 (-2.65%)
DIS   112.08 (-0.47%)
AMC   3.39 (+7.28%)
PFE   26.37 (+1.42%)
PYPL   62.73 (+0.67%)
XOM   120.59 (+0.59%)
NASDAQ:MASS

908 Devices (MASS) Stock Price, News & Analysis

$5.56
-0.02 (-0.36%)
(As of 11:44 AM ET)
Today's Range
$5.49
$5.66
50-Day Range
$5.58
$7.72
52-Week Range
$4.85
$12.51
Volume
34,348 shs
Average Volume
169,631 shs
Market Capitalization
$182.98 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$14.00

908 Devices MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
151.8% Upside
$14.00 Price Target
Short Interest
Bearish
4.84% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Selling Shares
$139,955 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($1.27) to ($1.15) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.99 out of 5 stars

Medical Sector

569th out of 907 stocks

Measuring & Controlling Devices, Not Elsewhere Classified Industry

6th out of 10 stocks

MASS stock logo

About 908 Devices Stock (NASDAQ:MASS)

908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling. Its products also comprise Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. The company operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of the Americas. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.

MASS Stock Price History

MASS Stock News Headlines

Healthcare Takes A Big Step Forward With The Help Of AI
The average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.
MASS Apr 2024 7.500 call
Healthcare Takes A Big Step Forward With The Help Of AI
The average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.
908 Devices Earnings Preview
908 Devices Q4 2023 Earnings Preview
908 Devices Inc. (MASS)
MASS Feb 2024 12.500 put
MASS Aug 2024 12.500 call
See More Headlines
Receive MASS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 908 Devices and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/05/2024
Today
4/22/2024
Next Earnings (Estimated)
5/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Measuring & controlling devices, not elsewhere classified
Sub-Industry
N/A
Current Symbol
NASDAQ:MASS
Fax
N/A
Employees
230
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$14.00
High Stock Price Target
$14.00
Low Stock Price Target
$14.00
Potential Upside/Downside
+151.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-36,400,000.00
Pretax Margin
-72.89%

Debt

Sales & Book Value

Annual Sales
$50.23 million
Book Value
$5.11 per share

Miscellaneous

Free Float
23,761,000
Market Cap
$182.98 million
Optionable
Optionable
Beta
0.93
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

  • Dr. Kevin J. Knopp Ph.D. (Age 51)
    Co-Founder, CEO, President & Director
    Comp: $788.88k
  • Dr. Christopher David Brown Ph.D. (Age 49)
    Co-Founder, Chief Product Officer & Co-Chair of Scientific Advisory Board
    Comp: $459.7k
  • Mr. Joseph H. Griffith IV (Age 49)
    CFO & Treasurer
    Comp: $468.98k
  • Mr. Steve Araiza
    Co-Founder
  • Mr. Andrew Bartfay
    Co-Founder & Director of Hardware Development
  • Mr. Michael Jobin
    Co-Founder & Director of Product Development
  • Dr. Scott Miller Ph.D.
    Co-founder & Director of MS Engineering
  • Mr. Michael S. Turner Esq. (Age 57)
    J.D., Chief Legal & Administrative Officer and Secretary
    Comp: $97.84k
  • Mr. Don Osmer (Age 58)
    Vice President of Human Resources

MASS Stock Analysis - Frequently Asked Questions

Should I buy or sell 908 Devices stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for 908 Devices in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" MASS shares.
View MASS analyst ratings
or view top-rated stocks.

What is 908 Devices' stock price target for 2024?

1 analysts have issued 12-month price objectives for 908 Devices' stock. Their MASS share price targets range from $14.00 to $14.00. On average, they predict the company's share price to reach $14.00 in the next twelve months. This suggests a possible upside of 151.8% from the stock's current price.
View analysts price targets for MASS
or view top-rated stocks among Wall Street analysts.

How have MASS shares performed in 2024?

908 Devices' stock was trading at $11.22 at the beginning of 2024. Since then, MASS shares have decreased by 50.4% and is now trading at $5.56.
View the best growth stocks for 2024 here
.

When is 908 Devices' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024.
View our MASS earnings forecast
.

How were 908 Devices' earnings last quarter?

908 Devices Inc. (NASDAQ:MASS) issued its quarterly earnings results on Tuesday, March, 5th. The company reported ($0.23) EPS for the quarter, beating the consensus estimate of ($0.26) by $0.03. The firm earned $14.40 million during the quarter, compared to analyst estimates of $14.16 million. 908 Devices had a negative trailing twelve-month return on equity of 21.09% and a negative net margin of 72.47%. 908 Devices's revenue was up 24.1% on a year-over-year basis. During the same period in the prior year, the business posted ($0.31) earnings per share.

What ETFs hold 908 Devices' stock?

ETFs with the largest weight of 908 Devices (NASDAQ:MASS) stock in their portfolio include ARK Genomic Revolution ETF (ARKG).Alger 35 ETF (ATFV).

What guidance has 908 Devices issued on next quarter's earnings?

908 Devices updated its FY 2024 earnings guidance on Wednesday, March, 6th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $52.0 million-$54.0 million, compared to the consensus revenue estimate of $55.5 million.

When did 908 Devices IPO?

908 Devices (MASS) raised $101 million in an IPO on Friday, December 18th 2020. The company issued 6,300,000 shares at $15.00-$17.00 per share. Cowen, SVB Leerink, Stifel and William Blair served as the underwriters for the IPO.

Who are 908 Devices' major shareholders?

908 Devices' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Sumitomo Mitsui Trust Holdings Inc. (1.71%). Insiders that own company stock include Christopher D Brown, Christopher D Brown, John Kenneweg, Joseph H Iv Griffith, Kevin J Knopp, Mark Spoto, Michael S Turner, Nicolas Barthelemy, Trent A Basarsky and Trent A Basarsky.
View institutional ownership trends
.

How do I buy shares of 908 Devices?

Shares of MASS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:MASS) was last updated on 4/22/2024 by MarketBeat.com Staff

From Our Partners